Abstract
AbstractFor the prosperity of Japan in the 21st century, we pediatricians play a very important role in securing the health of future adults. Although our infantile death rate has become one of the worlds lowest recently, the number of neonatal deaths can further be reduced by preventing infections and accidents. Because of the huge consumption of antibiotics in Japan for past decades, the drug resistance of pathogens has increased remarkably and we are forced to choose potent new antibiotics for saving neonatal lives. Some unsolved problems associated with GBS infection in Japan are mentioned and the necessity of development of immunopotentiators as well as chemotherapeutics and vaccines in treating neonatal infections is discussed.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
